SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-041606
Filing Date
2020-12-08
Accepted
2020-12-08 16:31:08
Documents
1
Period of Report
2020-12-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6049
  Complete submission text file 0001213900-20-041606.txt   7525
Mailing Address P.O. BOX 150183 AUSTIN TX 78715
Business Address P.O. BOX 150183 AUSTIN TX 78715 512-809-8549
Lung Therapeutics, Inc. (Reporting) CIK: 0001611241 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39102 | Film No.: 201375710

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Issuer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations